Carr Patricia reported option exercise involving 1,250 derivative units of Jazz Pharmaceuticals plc at $0.00 for $0 on Nov 4, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
SVP, Chief Accounting Officer
SVP, Chief Accounting Officer
Filed Nov 6, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
1,250Non-Qualified Stock Option (right to buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
3,000Direct
Trade date
Nov 4, 2026Option exercise
Filed
Nov 6, 2026, 5:19 PM ET2-day reporting delay
Accession
0001784606-26-000018Code M · Transaction 395207
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 4, 2026Sell1,250$231.37−$289,212.50Trade 395205
Nov 4, 2026Sell163$231.27−$37,697.01Trade 395206
Nov 4, 2026Option exercise1,250$140.03$175,037.50Trade 395204
4 transaction rows in this filing. Joint filers share the same rows.

JAZZ price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
JAZZ · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +0.5%1w ago −13%1d ago −2.1%
Returns since7d +2.9%30d90d180d1y

Footnotes in full

F1: The Reporting Person acquired 163 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026. F2: These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 28, 2019, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.